Six months after Merck & Co.'s manufacturing operations were crippled by a global cyberattack, the company says it has mostly recovered from the computer hack that took out its API production and affected its formulation and packaging systems, as well as R&D and other operations.
While those manufacturing problems are largely behind it, the Kenilworth, New Jersey-based company, like others, is now dealing with production interruptions in Puerto Rico after hurricanes there took out power, communications and transportation infrastructure.
“Other than sites in Puerto Rico, most of our manufacturing sites are now largely operational, meaning that we are manufacturing active pharmaceutical ingredient (API), formulating products and packing and shipping product,” a Merck spokeswoman said in an email.
Merck was the only pharma company to publicly acknowledge that it had systems affected by the Petya cyberattack in June, announcing it on Twitter. The attack infiltrated Microsoft systems that had not installed a needed security patch, taking control of computers and seeking a ransom in order for users to take back control. It had a worm-like capability that allowed it to spread across affected networks.